Asset
Mitapivat sulfate
Agios Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03991312 | phase1 | completed | 2019-06-20 | 2019-08-14 | Agios Pharmaceuticals, Inc. | Study to Evaluate the Effect of Multiple Doses of Itraconazole and Rifampin on the Single-Dose Pharmacokinetics of Mitapivat Sulfate (AG-348) in Healthy Adult Participants |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 216196 | NDA | AGIOS PHARMACEUTICALS INC |
Marketed products (4)
- AQVESME
- PYRUKYND
- PYRUKYND
- PYRUKYND